Sammy Caraballo Bonilla, MD
General Practice · San Juan, PRNPI 1497917447
Payments from drug & device makers
Across 121 payments — averaging $20.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Boehringer Ingelheim$487
- Johnson & Johnson$473
- Sanofi-aventis U.S. LLC$195
- Eli Lilly Export S.A. Puerto Rico Branch$73
- PBG Puerto Rico LLC$60
- plus $162 from 5 others
What the payments were for
- Food & beverage$2,489100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,040 |
| Boehringer Ingelheim | 22 | $487 |
| Johnson & Johnson | 21 | $473 |
| Sanofi-aventis U.S. LLC | 10 | $195 |
| Eli Lilly Export S.A. Puerto Rico Branch | 4 | $73 |
| PBG Puerto Rico LLC | 3 | $60 |
| Merck | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Abbott | 1 | $22 |
| GSK | 1 | $22 |
| Dexcom, Inc. | 1 | $17 |
How this compares
$2,489 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 307 | $280,320 |
| FarxigaDapagliflozin Propanediol | 210 | $203,836 |
| EliquisApixaban | 218 | $172,011 |
| Xigduo XrDapaglifloz Propaned/Metformin | 135 | $119,290 |
| SynthroidLevothyroxine Sodium | 952 | $83,166 |
| XareltoRivaroxaban | 95 | $79,036 |
| JardianceEmpagliflozin | 53 | $60,156 |
| JanumetSitagliptin Phos/Metformin Hcl | 59 | $58,897 |
| JanuviaSitagliptin Phosphate | 58 | $56,934 |
| TradjentaLinagliptin | 31 | $34,856 |
| JentaduetoLinagliptin/Metformin Hcl | 34 | $28,592 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 31 | $21,660 |
| OzempicSemaglutide | 21 | $20,571 |
| Atorvastatin Calcium | 1,699 | $20,321 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,077 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTrijardy Xr, Jardiance, Tradjenta, Jentadueto, Synjardy Xr | $487 | $447,230472 claims |
| AstraZenecaFarxiga, Brilinta | $1,040 | $212,179224 claims |
| MerckJanumet, Januvia, Janumet Xr | $55 | $137,490148 claims |
| Johnson & JohnsonXarelto | $473 | $79,03695 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $22 | $44,86285 claims |
| Sanofi-aventis U.S. LLCLantus | $195 | $17,456134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Other general practice in San Juan
- Gregorio Cortes-MaisonetSan Juan$12.8M
- Orvil MartinezSan Juan$211K
- Yudit Brito PequeroSan Juan$156K
- Miguel Sosa PadillaSan Juan$155K
- Vivian Tamayo AgraitSan Juan$96K
- William E TorresSan Juan$86K
- Roberto Unda GomezSan Juan$79K
- Eduardo Miralles AlonsoSan Juan$71K
- Victor PalmerSan Juan$21K
- Jose Davila SanchezSan Juan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.